Exenatide Treatment Causes Suppression of Serum Fasting Ghrelin Levels in Patients With Type 2 Diabetes Mellitus
Endocrine Abstracts
doi 10.1530/endoabs.49.gp112
Full Text
Open PDFAbstract
Available in full text
Date
May 3, 2017
Authors
Publisher
Bioscientifica